The end of the beginning for Novartis in India

The Madras court hearing the Novartis suit which argues that the Indian patent law runs contrary to the country’s TRIPs oligations has reserved its verdict and not stated when it is likely to hand down the decision. The court has also referred…

Get unlimited access to all IAM content